Niloticin inhibits osteoclastogenesis by blocking RANKL–RANK interaction and suppressing the AKT, MAPK, and NF-κB signaling pathways

Por Huanhuan Xu, Yuankan Jia, Jin Li, Xueqin Huang, Li Jiang, Ting Xiang, Yuanhao Xie, Xiaomei Yang, Titi Liu, Zemin Xiang, Jun Sheng
Publicado em 2022-05-01